Ciprandi, G <br/><br/>
Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.  [electronic resource] 

 -  International journal of immunopathology and pharmacology   
 - 1089-96 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0394-6320 
<br/><br/><label>Standard No.: </label>10.1177/039463200902200425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Sublingual<br/>Adult<br/>Antibodies--blood<br/>Antigens, Plant--administration & dosage<br/>Biomarkers--blood<br/>Cytokines--blood<br/>Desensitization, Immunologic<br/>Drug Administration Schedule<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Pollen--immunology<br/>Rhinitis, Allergic, Seasonal--blood<br/>Time Factors<br/>Transforming Growth Factor beta--blood<br/>Treatment Outcome<br/>Up-Regulation<br/>Young Adult